PXD-103

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePXD-103
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTopoTarget UK Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTopoTarget UK Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A